Blog
RSS FeedPosted by Michael Wonder on 04 Jan 2019
Kaitaia woman's life and death choice as PHARMAC says no to funding drug
28 December 2018 - Kaitaia mum Donna MacMillan is a glass-half-full kind of person despite being terminally ill with advanced ...
Posted by Michael Wonder on 02 Jan 2019
NHS England to fund Actelion's Uptravi
2 January 2019 - Actelion has announced that NHS patients in England, who have the rare, incurable and devastating disease ...
Posted by Michael Wonder on 02 Jan 2019
NHS to fund Afinitor for TSC-related epilepsy
2 January 2019 - NHS England has announced that from April this year it will fund Novartis' Afinitor (everolimus) for ...
Posted by Michael Wonder on 02 Jan 2019
Department update: implementation of the improved payment administration arrangements
2 January 2019 - A communique describing key achievements for 2018, and important next steps for 2019 is now available on ...
Posted by Michael Wonder on 02 Jan 2019
Schedule of Pharmaceutical Benefits - 1 January 2019 update
1 January 2019 - The January 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 02 Jan 2019
New Zealand Pharmaceutical Schedule - 1 January 2019 update
1 January 2019 - The January 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Dec 2018
Medicine for the treatment of seizures listed on the PBS
29 December 2018 - The Liberal National Government will make a medicine for the treatment of seizures associated with tuberous sclerosis ...
Posted by Michael Wonder on 28 Dec 2018
Rare lung cancer medication made available on the PBS
28 December 2018 - The Liberal National Government will make a medicine for a rare type of lung cancer caused by ...
Posted by Michael Wonder on 28 Dec 2018
Life-prolonging drug for rare cancer sufferers to be made more affordable with PBS listing
28 December 2018 - A life-prolonging medicine for sufferers of a rare lung cancer is to be made available for ...
Posted by Michael Wonder on 24 Dec 2018
Patients to save thousands as kidney drug goes on PBS list
24 December 2018 - An early Christmas present has been delivered to about 10,000 Australians suffering from a crippling kidney ...
Posted by Michael Wonder on 22 Dec 2018
Multiple sclerosis drug Mavenclad to be heavily subsidised in the new year under PBS
22 December 2018 - A multiple sclerosis drug will be heavily subsidised in the new year, saving sufferers $54,000 a year. ...
Posted by Michael Wonder on 21 Dec 2018
NICE recommends Lenvima for advanced liver cancer
21 December 2018 - NICE has recommended Eisai and MSD’s Lenvima (lenvatinib), a potentially life-extending treatment for advanced hepatocellular carcinoma ...
Posted by Michael Wonder on 20 Dec 2018
Merry Christmas and a Happy New Year to all MAESTrO Daily readers
21 December 2018 - This is the final issue for 2018; publication to resume on 7 January 2019. ...
Posted by Michael Wonder on 20 Dec 2018
Warning of rising drug prices as Britain prepares for no-deal Brexit
20 December 2018 - It comes as it was revealed that Matt Hancock has chartered a plane to airlift supplies. ...
Posted by Michael Wonder on 20 Dec 2018
Breast cancer drug lobbyists let down by PHARMAC's response to funding
20 December 2018 - Breast cancer sufferers have been dealt a blow in their mission to have life-extending drugs funded ...